SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001144204-11-040676
Filing Date
2011-07-15
Accepted
2011-07-15 06:01:12
Documents
4
Period of Report
2011-04-11
Filing Date Changed
2011-07-15
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v228777_8k.htm 8-K 28611
2 v228777_ex16-1.htm EX-16.1 11555
3 GRAPHIC footer.jpg GRAPHIC 10570
4 GRAPHIC logo1.jpg GRAPHIC 30745
  Complete submission text file 0001144204-11-040676.txt   98698
Mailing Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010
Business Address 409 CALLE SAN PABLO SUITE 100-101 CAMARILLO CA 93010 805-484-7687
Huifeng Bio-Pharmaceutical Technology, Inc. (Filer) CIK: 0001119951 (see all company filings)

IRS No.: 870650264 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32253 | Film No.: 11969020
SIC: 2833 Medicinal Chemicals & Botanical Products
Assistant Director 1